Riskpilot← Back to searchSign inGet full accessAQUAMEDIC AS
ASActiveOrg 997770765Hans Egedes Vei 7, 1470 LørenskogResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20126 employeeswww.aquamedic.no
Revenue 2024
NOK 4,4M
-26% vs 2023
EBITDA margin
-30.4%
-2002% vs 2023
Equity ratio
78.2%
Financial strength
Net profit 2024
NOK -966K
-252% vs 2023
| Revenue | NOK 4,4M | -26% |
| EBITDA | NOK -1,3M | -2002% |
| Net profit | NOK -966K | -252% |
| Total assets | NOK 5,4M | -25% |
| Equity | NOK 4,2M | -19% |
| Employees | 6 | — |
Legal name
AQUAMEDIC AS
Org number
997770765
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
2. januar 2012
Share capital
NOK 100 000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Drive konsulent- og oppdragsvirksomhet innen veterinærvitenskap og biomedisin, med særlig vekt på sykdomsforebygging og -kontroll i akvakultur.
Address
Hans Egedes Vei 7, 1470 Lørenskog
Email
info@aquamedic.no
Website
www.aquamedic.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 635 | 182 | 424 | 2 731 | 2 341 | 3 521 | 4 976 | 6 360 | 6 569 | 6 452 | 8 532 | 5 908 | 4 388 |
| Staff expenses | −401 | −123 | −29 | −1 005 | −1 322 | −1 719 | −1 884 | −2 803 | −3 774 | −3 563 | −3 618 | −3 940 | −3 491 |
| EBITDA | −31 | −217 | 138 | 1 108 | 443 | 623 | 1 175 | 1 019 | −45 | 1 033 | 1 185 | 70 | −1 332 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −30 | −33 | −54 | −65 | −65 |
| EBIT | −31 | −217 | 138 | 1 108 | 443 | 623 | 1 175 | 1 019 | −75 | 1 001 | 1 131 | 5 | −1 397 |
| Net financials | 0 | 1 | −0 | 1 | 2 | 5 | 5 | 71 | 67 | −127 | 144 | −75 | 466 |
| Profit before tax | −31 | −217 | 138 | 1 109 | 445 | 628 | 1 181 | 1 090 | −8 | 874 | 1 275 | −70 | −931 |
| Tax | −9 | −58 | 37 | 299 | 111 | −55 | 271 | 239 | −2 | 244 | 64 | 205 | 35 |
| Net profit | −23 | −158 | 101 | 810 | 334 | 683 | 910 | 851 | −6 | 630 | 1 210 | −274 | −966 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 522 | 404 | 666 | 2 130 | 2 305 | 3 091 | 4 207 | 4 787 | 5 315 | 5 769 | 7 048 | 7 186 | 5 388 |
| Equity | 77 | −81 | 220 | 1 029 | 1 363 | 2 046 | 2 956 | 3 610 | 3 878 | 4 508 | 5 452 | 5 178 | 4 212 |
| Long-term debt | 359 | 357 | 429 | 432 | 483 | 510 | 8 | 0 | 0 | 0 | 1 | 1 114 | 0 |
| Short-term debt | 85 | 128 | 18 | 669 | 459 | 536 | 1 243 | 1 021 | 1 437 | 1 261 | 1 595 | 893 | 1 176 |
| Total debt | 444 | 485 | 447 | 1 101 | 942 | 1 046 | 1 251 | 1 021 | 1 437 | 1 261 | 1 596 | 2 008 | 1 176 |
EBITDA margin
-30.4%
This company
15.8%
Market median
-292% vs market
20122024
Equity ratio
78.2%
This company
38.2%
Market median
+105% vs market
20122024
Return on equity
-22.9%
This company
18.4%
Market median
-224% vs market
20122024
Net profit margin
-22.0%
This company
8.1%
Market median
-372% vs market
20122024
Asset turnover
0.81×
This company
1.12×
Market median
+28% vs market
20122024
Debt / equity
0.28×
This company
0.62×
Market median
+55% vs market
20122024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2011-12-11 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JE Deputy Member | Deputy Member | 2012 | — | — |
PJ Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Chairman | 2012 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 25.0% | 25.0% | 2022 | |
| Individual | 12.5% | 12.5% | 2024 | |
| Individual | 12.5% | 12.5% | 2022 | |
| Individual | 12.5% | 12.5% | 2024 | |
| Individual | 12.5% | 12.5% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AQUAMEDIC AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Erling Herbert Midtlyng | Deputy Member | 0 companies |
| Paul Johan Midtlyng | Chief Executive Officer | 0 companies |
| Cornelia Ella Maria Schrøder Midtlyng | Deputy Chairman | 0 companies |